US experts recommend resuming J&J Covid vaccinations

US experts recommend resuming J&J Covid vaccinations
US experts recommend resuming J&J Covid vaccinations

Hello and welcome to the details of US experts recommend resuming J&J Covid vaccinations and now with the details

Nevin Al Sukari - Sana'a - A file photo taken on November 17, 2020 shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Johnson & Johnson in London. — AFP pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


WASHINGTON, Apr 24 — The United States should resume Johnson & Johnson Covid-19 vaccinations, an expert panel recommended to health authorities on Friday, after a pause prompted by blood clot concerns.

Health authorities in the United States on April 14 proposed a halt on the vaccine following instances of severe blood clots among the millions of Americans who received the vaccine.

The panel was 10 to 4 in favor of recommending the lifting of the pause, but the head of the Centers for Disease Control and Prevention (CDC) Rochelle Walensky will make the final decision.

“The Janssen Covid-19 vaccine is recommended for persons 18 years of age and older in the US population under the FDA, emergency use authorization,” the experts convened by the CDC said.

According to data presented Friday, of 3.9 million women who got the Johnson & Johnson shot, 15 developed serious blood clots and three died.

The majority of the confirmed cases, 13 of the 15, was aged under 50 years old. There were no reported cases among men.

Experts voiced support for the vaccine in a nation where over 570,000 people have died from the virus, the largest reported absolute death toll in the world.

“Removing a vaccine that can be given as a single dose and is a preference among Latinos in our communities, would be a detriment,” said Dr Jose Romero, chairman of CDC Advisory Committee on Immunization Practices.

Johnson & Johnson’s chief scientific officer Paul Stoffels welcomed the recommendation, saying it “is an essential step toward continuing urgently needed vaccinations in a safe way for millions of people in the US”.

Europe’s medicines regulator said Tuesday that blood clots should be listed as a “very rare” side effect of Johnson & Johnson’s coronavirus vaccine.

The regulator said its safety committee “concluded that a warning about unusual blood clots with low blood platelets should be added to the product information” for the J&J shot. — AFP

These were the details of the news US experts recommend resuming J&J Covid vaccinations for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV India’s seven-day COVID average at new high, WHO issues warning on strain
NEXT Myanmar shadow government’s militia gains popular support to fight military junta